KPNA4 and cancer: Wang et al. have demonstrated that the upregulation of the miR-181 family reverses the EMT by targeting karyopherin subunit alpha 4 (KPNA4), a gene whose protein product activates NF-κB-associated pathways critical for the EMT in multiple cancer types [113,114].